Equities

Novolog Pharm Up 1966 Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Novolog Pharm Up 1966 Ltd

Actions
Health CareHealth Care Providers
  • Price (ILa)115.80
  • Today's Change-2.80 / -2.36%
  • Shares traded373.11k
  • 1 Year change-31.36%
  • Beta0.7032
Data delayed at least 20 minutes, as of Feb 18 2026 15:24 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Novolog Pharm Up 1966 Ltd, formerly Pharm Up Ltd, is an Israel-based company, which operates in the health logistics sector. The Company is a logistical partner for domestic and multinational pharmaceutical and medical device companies operating in Israel. It mainly serves pharmacies, hospitals, and patients at home. The Company operates through its subsidiaries, which include: Care for Life-Professional Nurses Service, which provides a range of in-home services for patients by trained nurses and trained assistants, as well as Trialog-Clinical Trial Logistics, which specializes in logistics for clinical trials and works with pharmaceutical and Clinical Research Organization (CRO) companies that perform clinical trials in Israel.

  • Revenue in ILS (TTM)2.12bn
  • Net income in ILS12.40m
  • Incorporated1966
  • Employees936.00
  • Location
    Novolog Pharm Up 1966 Ltd55 Maayan st.MODIIN 7171300IsraelISR
  • Phone+972 86604400
  • Fax+972 86604404
  • Websitehttps://www.novolog.co.il/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Overseas Commerce Ltd368.82m19.93m309.12m356.0015.651.464.160.83820.35790.35796.613.840.5497--3.821,035,997.002.971.473.861.8121.4721.585.403.05--2.060.6361---4.450.2834141.07-0.6461-14.95--
Frontier Transport Holdings Ltd570.39m68.87m365.33m2.53k5.341.123.870.64051.201.209.805.681.05--12.79--12.7312.6915.7915.49----12.1412.881.3940.560.283750.8416.558.19-2.407.8317.296.99
Zeda Ltd2.06bn129.94m472.67m1.96k3.580.72571.410.22973.603.6057.0717.780.77186.426.695,427,815.004.985.009.689.4840.8839.886.456.461.232.390.6663--1.734.1512.28---19.78--
Novolog Pharm Up 1966 Ltd2.12bn12.40m605.90m936.0048.871.636.510.28550.02430.02434.150.72820.68216.521.162,267,107.000.41141.122.284.967.0110.630.60321.820.84252.560.35369.2923.0115.02194.1331.2918.62--
Data as of Feb 18 2026. Currency figures normalised to Novolog Pharm Up 1966 Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

52.84%Per cent of shares held by top holders
HolderShares% Held
Migdal Makefet Pension & Provident Funds Ltd.as of 30 Jun 202571.20m13.94%
Harel Provident Funds Ltd.as of 30 Jun 202562.21m12.18%
Phoenix Provident Fund Ltd.as of 17 Sep 202561.28m12.00%
Clal Pension & Provident Funds Ltd.as of 30 Jun 202532.72m6.40%
Excellence Nessuah Mutual Funds Management Ltd.as of 17 Sep 202513.53m2.65%
Yelin Lapidot Mutual Fund Management Ltd.as of 30 Nov 202512.49m2.45%
Ayalon Mutual Funds Ltd.as of 30 Nov 20255.23m1.02%
Psagot Mutual Funds Ltd.as of 30 Nov 20255.12m1.00%
Meitav Mutual Funds Ltd.as of 30 Nov 20253.20m0.63%
Harel Mutual Funds Ltd.as of 30 Jun 20252.94m0.58%
More ▼
Data from 30 Nov 2025 - 09 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.